First Light Asset Management, LLC
- SEC CIK
- 0001600004
- Latest filing
- Aug 14, 2026
Holdings in Q2 2023
Holdings as of Jun 30, 2023, filed Aug 14, 2023. Long positions only; changes compare share counts with Q1 2023.
- Positions
- 79
- +5 vs. Q1 2023
- Portfolio value
- $1.28B
- +$165.3M (+14.9%) vs. Q1 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| RETAReata Pharmaceuticals Inc | CL A | 1,432,208 | $146.0M | 11.4% | −154,720−9.7% | Reduced | History |
| PRTAProthena Corp Public Ltd Co | SHS | 1,500,129 | $102.4M | 8.0% | −11,039−0.7% | Reduced | History |
| ATRCAtriCure, Inc. | COM | 1,461,635 | $72.1M | 5.7% | +2,578+0.2% | Added | History |
| MODNModel N, Inc. | COM | 1,865,525 | $66.0M | 5.2% | +11,852+0.6% | Added | History |
| SIBNSI-BONE, Inc. | COM | 2,114,829 | $57.1M | 4.5% | +6170.0% | Added | History |
| ATECAlphatec Holdings, Inc. | COM NEW | 2,971,877 | $53.4M | 4.2% | +27,752+0.9% | Added | History |
| KRTXKaruna Therapeutics, Inc. | COM | 208,746 | $45.3M | 3.5% | −34,929−14.3% | Reduced | History |
| OFIXOrthofix Medical Inc. | COM | 2,459,129 | $44.4M | 3.5% | −191,842−7.2% | Reduced | History |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 1,739,449 | $44.4M | 3.5% | +1,040,121+148.7% | Added | History |
| NEONeogenomics Inc | COM NEW | 2,692,057 | $43.3M | 3.4% | −6,901−0.3% | Reduced | History |
| FNAParagon 28, Inc. | COM | 2,057,307 | $36.5M | 2.9% | +19,368+1.0% | Added | History |
| PLRXPliant Therapeutics, Inc. | COM | 1,810,176 | $32.8M | 2.6% | +384,822+27.0% | Added | History |
| HCATHealth Catalyst, Inc. | COM | 2,540,959 | $31.8M | 2.5% | +560,642+28.3% | Added | History |
| TMDXTransMedics Group, Inc. | COM | 377,464 | $31.7M | 2.5% | +39,552+11.7% | Added | History |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 1,557,222 | $28.1M | 2.2% | −61,903−3.8% | Reduced | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 589,963 | $27.2M | 2.1% | +354,186+150.2% | Added | History |
| OPRXOptimizeRx Corp | COM NEW | 1,871,799 | $26.7M | 2.1% | +860,868+85.2% | Added | History |
| PHLTPerformant Healthcare Inc | COM | 9,249,683 | $25.0M | 2.0% | +1,038,984+12.7% | Added | History |
| OMCLOmnicell, Inc. | COM | 321,664 | $23.7M | 1.9% | −11,845−3.6% | Reduced | History |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 757,835 | $21.4M | 1.7% | +757,835 | New | History |
| HALOHalozyme Therapeutics, Inc. | COM | 584,248 | $21.1M | 1.7% | −103,958−15.1% | Reduced | History |
| KRMDKORU Medical Systems, Inc. | COM | 5,299,639 | $18.3M | 1.4% | −891,678−14.4% | Reduced | History |
| AXGNAxogen, Inc. | COM | 1,973,699 | $18.0M | 1.4% | +32,603+1.7% | Added | History |
| TCMDTactile Systems Technology Inc | COM | 711,345 | $17.7M | 1.4% | +11,345+1.6% | Added | History |
| TELATELA Bio, Inc. | COM | 1,725,500 | $17.5M | 1.4% | +1,725,500 | New | History |
| Abcam PLC000380204 | ADS | 710,745 | $17.4M | 1.4% | +331,034+87.2% | Added | – |
| KROSKeros Therapeutics, Inc. | COM | 416,830 | $16.7M | 1.3% | −177,134−29.8% | Reduced | History |
| AXNXAxonics, Inc. | COM | 312,786 | $15.8M | 1.2% | +3,546+1.1% | Added | History |
| SCTLSocietal CDMO, Inc. | COM | 13,405,030 | $14.7M | 1.2% | +4,488,160+50.3% | Added | History |
| TNDMTandem Diabetes Care Inc | COM NEW | 600,767 | $14.7M | 1.2% | +11,582+2.0% | Added | History |
| OMOutset Medical, Inc. | COM | 637,422 | $13.9M | 1.1% | +637,422 | New | History |
| INSMINSMED Inc | COM PAR $.01 | 645,686 | $13.6M | 1.1% | −105,197−14.0% | Reduced | History |
| KIDSOrthopediatrics Corp | COM | 298,976 | $13.1M | 1.0% | −2,603−0.9% | Reduced | History |
| XENEXenon Pharmaceuticals Inc. | COM | 338,646 | $13.0M | 1.0% | +59,202+21.2% | Added | History |
| KRYSKrystal Biotech, Inc. | COM | 101,259 | $11.9M | 0.9% | −94,721−48.3% | Reduced | History |
| CUTRCutera Inc | COM | 570,729 | $8.64M | 0.7% | +861+0.2% | Added | History |
| MXCTMaxcyte, Inc. | COM | 1,857,566 | $8.53M | 0.7% | +493,344+36.2% | Added | History |
| GHGuardant Health, Inc. | COM | 197,704 | $7.08M | 0.6% | −7,141−3.5% | Reduced | History |
| ANABAnaptysbio, Inc | COM | 322,208 | $6.55M | 0.5% | +322,208 | New | History |
| GMABGenmab A/S | SPONSORED ADS | 158,509 | $6.02M | 0.5% | −1,516−0.9% | Reduced | History |
| SONXSonendo, Inc. | COM | 4,185,619 | $5.69M | 0.4% | 00.0% | Unchanged | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 60,654 | $5.26M | 0.4% | −828−1.3% | Reduced | History |
| PFEPfizer Inc | Stock | 140,235 | $5.14M | 0.4% | −1,312−0.9% | Reduced | History |
| MIROMiromatrix Medical Inc. | COM | 2,225,740 | $3.90M | 0.3% | −8,916−0.4% | Reduced | History |
| STVNStevanato Group S.p.A. | ORD SHS | 114,276 | $3.70M | 0.3% | −1,080−0.9% | Reduced | History |
| TECHBIO-TECHNE Corp | COM | 33,178 | $2.71M | 0.2% | +33,178 | New | History |
| CSTLCastle Biosciences Inc | COM | 160,126 | $2.20M | 0.2% | −1,492−0.9% | Reduced | History |
| OKUROnKure Therapeutics, Inc. | COM | 250,000 | $1.64M | 0.1% | +250,000 | New | History |
| SLPSimulations Plus, Inc. | COM | 35,355 | $1.53M | 0.1% | −348−1.0% | Reduced | History |
| SNNSmith & Nephew PLC | SPDN ADR NEW | 15,111 | $487.3K | <0.1% | 00.0% | Unchanged | History |
| FMSFresenius Medical Care AG | SPONSORED ADR | 19,490 | $466.4K | <0.1% | 00.0% | Unchanged | History |
| ENOVEnovis CORP | COM | 7,203 | $461.9K | <0.1% | 00.0% | Unchanged | History |
| NVSNovartis AG | ADR | 4,123 | $416.1K | <0.1% | 00.0% | Unchanged | History |
| SNYSanofi | SPONSORED ADR | 7,711 | $415.6K | <0.1% | 00.0% | Unchanged | History |
| TAKTakeda Pharmaceutical Co Ltd | ADR | 25,630 | $402.6K | <0.1% | 00.0% | Unchanged | History |
| HUMHumana Inc | Stock | 888 | $397.1K | <0.1% | 00.0% | Unchanged | History |
| ELVElevance Health, Inc. | Stock | 886 | $393.6K | <0.1% | 00.0% | Unchanged | History |
| CNCCentene Corp | Stock | 5,521 | $372.4K | <0.1% | 00.0% | Unchanged | History |
| MDTMedtronic plc | Stock | 4,188 | $369.0K | <0.1% | 00.0% | Unchanged | History |
| GSKGSK plc | ADR | 10,058 | $358.5K | <0.1% | 00.0% | Unchanged | History |
| JNJJohnson & Johnson | Stock | 2,161 | $357.7K | <0.1% | 00.0% | Unchanged | History |
| QDELQuidelOrtho Corp | COM | 4,257 | $352.7K | <0.1% | 00.0% | Unchanged | History |
| EXELExelixis, Inc. | COM | 18,445 | $352.5K | <0.1% | 00.0% | Unchanged | History |
| Bayer AG072730302 | Common Stock | 25,475 | $352.1K | <0.1% | 00.0% | Unchanged | – |
| HCAHCA Healthcare, Inc. | COM | 1,160 | $352.0K | <0.1% | 00.0% | Unchanged | History |
| GILDGilead Sciences, Inc. | Stock | 4,526 | $348.8K | <0.1% | 00.0% | Unchanged | History |
| VTRSViatris Inc | Stock | 33,010 | $329.4K | <0.1% | 00.0% | Unchanged | History |
| XRAYDentsply Sirona Inc. | Stock | 8,228 | $329.3K | <0.1% | 00.0% | Unchanged | History |
| BIIBBiogen Inc. | COM | 1,096 | $312.2K | <0.1% | 00.0% | Unchanged | History |
| QGENQiagen N.V. | SHS NEW | 6,912 | $311.2K | <0.1% | 00.0% | Unchanged | History |
| PDCOPatterson Companies, Inc. | COM | 9,264 | $308.1K | <0.1% | 00.0% | Unchanged | History |
| AVTRAvantor, Inc. | COM | 14,596 | $299.8K | <0.1% | 00.0% | Unchanged | History |
| IARTIntegra Lifesciences Holdings Corp | COM NEW | 7,261 | $298.6K | <0.1% | 00.0% | Unchanged | History |
| UTHRUnited Therapeutics Corp | COM | 1,345 | $296.9K | <0.1% | 00.0% | Unchanged | History |
| LHLabcorp Holdings Inc. | COM NEW | 1,218 | $293.9K | <0.1% | 00.0% | Unchanged | History |
| AKUAkumin Inc. | COM | 1,575,098 | $283.5K | <0.1% | −1,964,400−55.5% | Reduced | History |
| OGNOrganon & Co. | Stock | 12,716 | $264.6K | <0.1% | 00.0% | Unchanged | History |
| RVTYRevvity, Inc. | COM | 2,223 | $264.1K | <0.1% | 00.0% | Unchanged | History |
| SYNHSyneos Health, Inc. | CL A | 5,736 | $241.7K | <0.1% | 00.0% | Unchanged | History |
Sold out since Q1 2023 (1)
Positions held at the end of Q1 2023 that are gone from this filing.
| Security | Class | Shares in Q1 2023 | Value in Q1 2023 | % of portfolio in Q1 2023 | History |
|---|---|---|---|---|---|
| Bellus Health Inc New07987C204 | COM NEW | 3,020,393 | $21.7M | 2.0% | – |